HCA Healthcare Shares Plummets 1.07% as Volume Ranks 245th Amid Rising Rates and Operational Challenges

On October 13, 2025, HCA Healthcare (HCA) closed with a 1.07% decline, trading at a volume of $0.44 billion, a 35.65% drop from the prior day’s activity. The stock ranked 245th in terms of trading volume across the market.

Recent developments suggest mixed sentiment toward the healthcare provider. A regulatory filing highlighted potential operational challenges in its outpatient services division, though no immediate financial penalties were indicated. Analysts noted the decline could reflect broader sector pressures amid rising interest rates, which often weigh on healthcare stocks due to their sensitivity to borrowing costs.

Historical performance data from January 1, 2022, to October 13, 2025, reveals a total return of 29.66% for HCA, with an annualized return of 8.02%. The strategy of buying the stock when its 14-day RSI fell below 30 and exiting the next session yielded an average trade profit/loss of 0.86%, despite experiencing maximum drawdowns of 12.92% and a Sharpe ratio of 0.53. While short-term rebounds were captured effectively, the approach faced occasional losses of 6-7% per trade.